See the DrugPatentWatch profile for hydrogenated
What is HSPC, and how is it different from DSPC?
HSPC (hydrogenated soy phosphatidylcholine) and DSPC (distearoyl phosphatidylcholine) are both phosphatidylcholine (PC) lipids used to build lipid mixtures for drug delivery (including liposomes), but they come from different sources and have different fatty-acid profiles.
- HSPC is made from soy-derived phosphatidylcholine that is hydrogenated, which increases the saturation of the fatty-acid chains and makes the lipid mixture more chemically stable and more ordered than native soy PC.
- DSPC is a single, defined phospholipid: distearoyl-PC, meaning it has two saturated C18:0 (stearic acid) chains. Because it is more chemically defined, DSPC typically gives higher phase-transition temperatures and stronger membrane rigidity than soy-based hydrogenated blends.
In practical formulation terms, HSPC and DSPC are often used as “high-transition/rigid” PC lipids, but DSPC tends to be more uniform, while HSPC can be closer to a mixture-like profile.
Is HSPC “the same as” DSPC?
No. HSPC and DSPC are not the same lipid.
Even though both are used to create rigid or stable liposomal membranes, HSPC is hydrogenated soy PC (a mixture), while DSPC is distearoyl PC (a defined molecule). That difference affects membrane packing, phase behavior, and how the lipid interacts with cholesterol and other excipients.
How does a DSPC-containing lipid system typically behave versus an HSPC-containing one?
Because DSPC is more uniformly distearoyl-PC, it usually:
- forms more tightly packed bilayers,
- can raise the lipid’s characteristic transition/gel-to-liquid behavior compared with hydrogenated soy blends.
HSPC is also saturated and more rigid than unsaturated soy PC, but its soy-derived composition can include slight variability versus the fully defined DSPC structure. That can translate into differences in:
- bilayer fluidity at temperature,
- leakage and stability,
- how closely formulation performance matches across manufacturing lots.
Where does “DSPC vs HSPC” matter in drug products?
It matters when a formulation relies on lipid phase properties to control release and stability, such as liposomes and lipid nanoparticles (LNPs). Small differences in lipid composition can change:
- membrane permeability (drug leakage),
- circulation stability,
- interaction with proteins and lipolytic enzymes,
- sensitivity to storage temperature.
What should you check if you’re selecting between HSPC and DSPC?
Look at the exact product specification and phase/thermal data provided by the supplier or in the drug’s formulation description, because:
- “HSPC” can refer to different supplier manufacturing profiles,
- “DSPC” is defined but can still be used in different molar ratios with cholesterol and helper lipids (which strongly affects behavior).
If you share the specific formulation or label text you’re looking at (drug name or the excipient list/molar ratios), I can help map whether it uses HSPC, DSPC, or a blend and what that usually implies for membrane properties.